Characterization of pathologic complete response after preoperative chemoradiotherapy in carcinoma of the esophagus and outcome after pathologic complete response

Cancer

Volumn 104, Issue 11, 2005, Pages 2365-2372

  Rohatgi, Pooja ^a   Swisher, Stephen C ^a   Correa, Arlene M ^a   Wu, Tsung T ^a   Liao, Zhongxing ^a   Komaki, Ritsuko ^a   Walsh, Garrett L ^a   Vaporciyan, Ara A ^a   Rice, David C ^a   Roth, Jack A ^a   Ajani, Jaffer A ^a,b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b Department of Gastrointestinal Medical Oncology ^*  (United States)

Author keywords

Carcinoma; Esophagus; Pathologic complete response (pathCR); Preoperative chemoradiation

Indexed keywords

CAMPTOTHECIN; CISPLATIN; DOCETAXEL; FLUOROURACIL; IRINOTECAN; PACLITAXEL;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RADIATION DOSE; SEX DIFFERENCE; TREATMENT OUTCOME; TUMOR LOCALIZATION;

ADENOCARCINOMA; ADULT; AGED; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 28044442478     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.21439     Document Type: Article

References (34)

1. Jemal A, Clegg LX, Ward E, et al. Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival. Cancer. 2004;101:3-27.
2. Coia LR, Minsky BD, Berkey BA, et al. Outcome of patients receiving radiation for cancer of the esophagus: results of the 1992-1994 Patterns of Care Study. J Clin Oncol. 2000;18: 455-462.
3. Walsh TN, Noonan N, Hollywood D, et al. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med. 1996;335:462-467.
4. Urba SG, Orringer MB, Turrisi A, et al. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol. 2001;19:305-313.
5. Bosset JF, Gignoux M, Triboulet JP, et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med. 1997; 337:161-167.
6. Kelsen DP, Ginsberg R, Pajak TF, et al. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med. 1998;339:1979-1984.
7. Medical Research Council Oesophageal Cancer Working Group. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet. 2002;359:1727-1733.
8. Heath EI, Burtness BA, Heitmiller RF, et al. Phase II evaluation of preoperative chemoradiation and postoperative adjuvant chemotherapy for squamous cell and adenocarcinoma of the esophagus. J Clin Oncol. 2000;18:868-876.
9. Forastiere AA, Orringer MB, Perez-Tamayo C, et al. Concurrent chemotherapy and radiation therapy followed by transhiatal esophagectomy for local-regional cancer of the esophagus. J Clin Oncol. 1990;8:119-127.
10. Ajani JA, Komaki R, Putnam JB, et al. A three-step strategy of induction chemotherapy then chemoradiation followed by surgery in patients with potentially resectable carcinoma of the esophagus of gastroesophageal junction. Cancer. 2001; 92:279-286.
11. Ajani JA, Walsh G, Komaki R, et al. Preoperative induction CPT-11 and cisplatin chemotherapy followed by chemoradiotherapy in patients with local-regional carcinoma of the esophagus or gastroesophageal junction. Cancer. 2004;100: 2347-2354.
12. Malthaner R, Fenlon D. Preoperative chemotherapy for resectable thoracic esophageal cancer. Cochrane Database Syst Rev. 2003;CD001556.
13. Darnton SJ, Archer VR, Stocken DD, et al. Preoperative mitomycin, ifosfamide, and cisplatin followed by esophagectomy in squamous cell carcinoma of the esophagus: pathologic complete response induced by chemotherapy leads to long-term survival. J Clin Oncol. 2003;21:4009-4015.
14. Meluch AA, Greco FA, Gray JR, et al. Preoperative therapy with concurrent paclitaxel/carboplatin/infusional 5-FU and radiation therapy in locoregional esophageal cancer: final results of a Minnie Pearl Cancer Research Network phase II trial. Cancer J. 2003;9:251-260.
15. Poplin E, Fleming T, Leichman L, et al. Combined therapies for squamous-cell carcinoma of the esophagus, a Southwest Oncology Group Study (SWOG-8037). J Clin Oncol. 1987;5: 622-628.
16. Szumilo J, Chibowski D, Dabrowski A. Assessment of the predictive value of clinical and histopathological factors as well as the immunoexpression of p53 and bcl-2 proteins in the response to preoperative chemotherapy for esophageal squamous cell carcinoma. Dis Esophagus. 2000;13:191-197.
17. Ganem G, Dubray B, Raoul Y, et al. Concomitant chemoradiotherapy followed, where feasible, by surgery for cancer of the esophagus. J Clin Oncol. 1997;15:701-711.
18. Stahl M, Wilke H, Fink U, et al. Combined preoperative chemotherapy and radiotherapy in patients with locally advanced esophageal cancer. Interim analysis of a phase II trial. J Clin Oncol. 1996;14:829-837.
19. Stockeld D, Tennvall I, Wagenius G, et al. A Swedish study of chemoradiation in squamous cell carcinoma of the esophagus. Acta Oncol. 2001;40:566-573.
20. Vogel SB, Mendenhall WM, Sombeck MD. Downstaging of esophageal cancer after preoperative radiation and chemotherapy. Ann Surg. 1995;221:685-695.
21. Forastiere AA, Heitmiller RF, Lee DJ, et al. Intensive chemoradiation followed by esophagectomy for squamous cell and adenocarcinoma of the esophagus. Cancer J Sci Am. 1997;3:144-152.
22. Forastiere AA, Orringer MB, Perez-Tamayo C, et al. Preoperative chemoradiation followed by transhiatal esophagectomy for carcinoma of the esophagus: final report. J Clin Oncol. 1993;11:1118-1123.
23. Meneu-Diaz JC, Blazquez LA, Vicente E, et al. The role of multimodality therapy for resectable esophageal cancer. Am J Surg. 2000;179:508-513.
24. Donington JS, Miller DL, Allen MS, et al. Tumor response to induction chemoradiation: influence on survival after esophagectomy. Eur J Cardiothorac Surg. 2003;24:631-637.
25. De Vita F, Di Martino N, Orditura M, et al. Preoperative chemoradiotherapy for squamous cell carcinoma and adenocarcinoma of the esophagus: a phase II study. Chest. 2002;122:1302-1308.
26. Slater MS, Holland J, Faigel DO, et al. Does neoadjuvant chemoradiation downstage esophageal carcinoma? Am J Surg. 2001;181:440-444.
27. Kim JH, Choi EK, Kim SB, et al. Preoperative hyperfractionated radiotherapy with concurrent chemotherapy in resectable esophageal cancer. Int J Radiat Oncol Biol Phys. 2001;50:1-12.
28. Imdahl A, Jenkner J, Ihling C, et al. Is MIB-1 proliferation index a predictor for response to neoadjuvant therapy in patients with esophageal cancer? Am J Surg. 2000;179:514-520.
29. Makary MA, Kiernan PD, Sheridan MJ, et al. Multimodality treatment for esophageal cancer: the role of surgery and neoadjuvant therapy. Am Surg. 2003;69:693-702.
30. Tsujinaka T, Shiozaki H, Yamamoto M, et al. Role of preoperative chemoradiation in the management of upper third thoracic esophageal squamous cell carcinoma. Am J Surg. 1999;177:503-506.
31. Suntharalingam M, Haas ML, Sonett JR, et al. Accurate lymph node assessment prior to trimodality therapy for esophageal carcinoma. Cancer J. 2001;7:509-515.
32. Green FL, Page DL, Fleming ID, et al. Esophagus. In: Green FL, Page DL, Fleming ID, et al., editors. AJCC cancer staging manual, 6th ed. New York: Springer-Verlag, 2002:91-98.
33. Ajani JA, Mansfield PF, Janjan N, et al. A multi-institutional trial of preoperative chemoradiotherapy in patients with potentially resectable gastric carcinoma. J Clin Oncol. 2004; 22:2774-2780.
34. Ura T, Muro K, Shimada K, et al. Definitive chemoradiotherapy may be the standard treatment option in clinical stage I esophageal cancer [abstract 4017]. Proc Am Soc Clin Oncol. 2004;23:316.